Agilon Health (AGL) Q2 Revenue Falls 6%
Werte in diesem Artikel
Agilon Health (NYSE:AGL), a company that supports primary care physicians through a value-based care platform, reported earnings on August 4, 2025. Headline results were meaningfully weaker than expected. GAAP revenue totaled $1.39 billion, missing the consensus GAAP estimate of $1,471.84 million, and GAAP earnings per share came in at $(0.25). The company also announced it was withdrawing its full-year 2025 financial guidance amid ongoing headwinds and a recent CEO transition. Overall, the period was marked by deteriorating membership, falling revenue, and notable negative swings in key profitability measures, setting a cautious tone for the near term. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Agilon Health helps community-based physician groups transition to a value-based healthcare model. Its platform is designed to support physicians as they shift from traditional fee-for-service care, which emphasizes the number of services delivered, to value-based care that rewards improvements in quality and efficiency. The company forms long-term partnerships, usually spanning 20 years, with these groups and uses proprietary technology, including tools for data aggregation, care gap identification, and quality monitoring.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf agilon health
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf agilon health
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: MotleyFool
Nachrichten zu Q2 Holdings Inc
Analysen zu Q2 Holdings Inc
Datum | Rating | Analyst | |
---|---|---|---|
13.08.2019 | Q2 Buy | Compass Point | |
01.03.2019 | Q2 Buy | Needham & Company, LLC | |
19.12.2018 | Q2 Buy | BTIG Research | |
09.08.2018 | Q2 Buy | Needham & Company, LLC | |
11.05.2018 | Q2 Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
11.05.2018 | Q2 Neutral | BTIG Research | |
18.11.2016 | Q2 Sector Weight | Pacific Crest Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Q2 Holdings Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen